TELA Bio is a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions. Co.'s main product, the OviTex Reinforced Tissue Matrix (OviTex), addresses needs in hernia repair and abdominal wall reconstruction by combining the benefits of biologic matrices and polymer materials. Co. has designed an OviTex product for use in laparoscopic and robotic-assisted surgery called OviTex LPR. Co.'s other product, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses needs in plastic and reconstructive surgery. Co.'s OviTex PRS portfolio is supported by non-human primate data that demonstrated tissue integration and tissue remodeling. We show 12 historical shares outstanding datapoints in our coverage of TELA's shares outstanding history.
Understanding the changing numbers of TELA shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like TELA versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching TELA by allowing them to research TELA shares outstanding history
as well as any other stock in our coverage universe. |
Free TELA Email Alerts:
Video: Shares Outstanding Importance
